Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$0.76 - $1.19 $163 - $255
215 Added 25.63%
1,054 $0
Q2 2023

Aug 04, 2023

BUY
$0.45 - $0.97 $377 - $813
839 New
839 $0
Q2 2022

Aug 03, 2022

SELL
$1.03 - $2.05 $16,696 - $33,230
-16,210 Reduced 65.96%
8,365 $11,000
Q1 2022

May 02, 2022

BUY
$1.25 - $2.31 $30,718 - $56,768
24,575 New
24,575 $37,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $98.5M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.